{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:47:55Z","timestamp":1791305275891,"version":"4.3.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bone.2010.06.007","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T09:03:28Z","timestamp":1276765408000},"page":"44-53","source":"Crossref","is-referenced-by-count":88,"title":["Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis"],"prefix":"10.1016","volume":"48","author":[{"given":"Conor C.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2010.06.007_bb0005","unstructured":"www.cancer.org. Cancer Facts and Figures. American Cancer Society 2008."},{"key":"10.1016\/j.bone.2010.06.007_bb0010","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.2741\/2311","article-title":"Biology and clinical management of prostate cancer bone metastasis","volume":"12","author":"Ye","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.bone.2010.06.007_bb0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1, 589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bone.2010.06.007_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0025","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.10662","article-title":"Prostate cancer bone metastases promote both osteolytic and osteoblastic activity","volume":"91","author":"Keller","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2010.06.007_bb0030","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/1078-0432.CCR-08-1572","article-title":"Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference","volume":"14","author":"Coleman","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0035","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0040","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.blo.0000093844.72468.f4","article-title":"Breast cancer metastasis to bone: it is not all about PTHrP","volume":"2","author":"Bendre","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bone.2010.06.007_bb0050","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","article-title":"Prostate cancer cells promote osteoblastic bone metastases through Wnts","volume":"65","author":"Hall","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0055","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-07-6541","article-title":"Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms","volume":"68","author":"Dai","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0060","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1830978100","article-title":"A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases","volume":"100","author":"Yin","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2010.06.007_bb0065","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0070","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1073\/pnas.83.7.2228","article-title":"Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro","volume":"83","author":"Ibbotson","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2010.06.007_bb0075","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI112677","article-title":"Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures","volume":"78","author":"Takahashi","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2010.06.007_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jbmr.5650080509","article-title":"Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1","volume":"8","author":"Guise","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0085","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M","article-title":"Parathyroid hormone-related protein and bone metastases","volume":"80","author":"Guise","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2010.06.007_bb0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.2528207","article-title":"Osteoclastic bone resorption by a polarized vacuolar proton pump","volume":"245","author":"Blair","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bone.2010.06.007_bb0100","first-page":"223","article-title":"Lund, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkegaard T, Lenhard T, Heegaard AM, Neff L, Baron R, Foged NT. Proteinases in bone resorption: obvious and less obvious roles","volume":"291","author":"Delaisse","year":"2000","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bone.2010.06.007_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1402.073","article-title":"Perspective on the osteoclast: an angiogenic cell?","volume":"1117","author":"Cackowski","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bone.2010.06.007_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1432-0436.2002.700909.x","article-title":"Matrix metalloproteinases in tumor\u2013host cell communication","volume":"70","author":"Lynch","year":"2002","journal-title":"Differentiation"},{"key":"10.1016\/j.bone.2010.06.007_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bone.2010.06.007_bb0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities","volume":"61","author":"Delaisse","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.bone.2010.06.007_bb0125","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","article-title":"The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation","volume":"18","author":"Garnero","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jnci\/94.1.17","article-title":"Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis","volume":"94","author":"Nemeth","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bone.2010.06.007_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pros.20318","article-title":"CXCL12\/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12","volume":"66","author":"Chinni","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.bone.2010.06.007_bb0140","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2353\/ajpath.2007.060720","article-title":"Trindade Filho JC, Sabbota A, Osenkowski P, Nabha S, Yamamoto H, Chinni SR, Zhao H, Mobashery S, Vessella RL, Fridman R, Cher ML. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth","volume":"170","author":"Bonfil","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2010.06.007_bb0145","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/ijc.23431","article-title":"Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner","volume":"122","author":"Nabha","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10585-009-9279-2","article-title":"Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor\u2013bone interaction potentiates mammary tumor-induced osteolysis","volume":"26","author":"Nannuru","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bone.2010.06.007_bb0155","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/0008-5472.CAN-0384-2","article-title":"Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice","volume":"64","author":"Tester","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0160","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","article-title":"ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis","volume":"23","author":"Lu","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2010.06.007_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor\u2013bone interactions in osteolytic metastases","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.bone.2010.06.007_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S8756-3282(98)00064-7","article-title":"Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development","volume":"23","author":"Bord","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.007_bb0175","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1359\/jbmr.1999.14.11.1880","article-title":"Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro","volume":"14","author":"Breckon","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/8756-3282(96)00106-8","article-title":"Production of collagenase by human osteoblasts and osteoclasts in vivo","volume":"19","author":"Bord","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.007_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)80064-1","article-title":"MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover","volume":"99","author":"Holmbeck","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.06.007_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s004410050036","article-title":"Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone","volume":"299","author":"Dew","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0195","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/en.139.3.1338","article-title":"Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption","volume":"139","author":"Kusano","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.06.007_bb0200","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.matbio.2005.06.009","article-title":"Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases","volume":"24","author":"Parikka","year":"2005","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0205","doi-asserted-by":"crossref","first-page":"33814","DOI":"10.1074\/jbc.M607290200","article-title":"A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism","volume":"281","author":"Inoue","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/370061a0","article-title":"A matrix metalloproteinase expressed on the surface of invasive tumour cells","volume":"370","author":"Sato","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bone.2010.06.007_bb0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1242\/jcs.01581","article-title":"The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone","volume":"118","author":"Holmbeck","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bone.2010.06.007_bb0220","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1073\/pnas.0407788101","article-title":"Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification","volume":"101","author":"Inada","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2010.06.007_bb0225","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1242\/dev.01461","article-title":"Altered endochondral bone development in matrix metalloproteinase 13-deficient mice 2","volume":"131","author":"Stickens","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.bone.2010.06.007_bb0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ng1249","article-title":"Loss of collagenase-2 confers increased skin tumor susceptibility to male mice","volume":"35","author":"Balbin","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2010.06.007_bb0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","article-title":"MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL","volume":"7","author":"Lynch","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2010.06.007_bb0240","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-08-3949","article-title":"Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis","volume":"69","author":"Thiolloy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0245","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2004.06.019","article-title":"A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells","volume":"35","author":"Andersen","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.007_bb0250","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2010.06.007_bb0255","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","article-title":"Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization","volume":"14","author":"Gowen","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"Pt 1","key":"10.1016\/j.bone.2010.06.007_bb0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/bj2790167","article-title":"Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase","volume":"279","author":"Delaisse","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.bone.2010.06.007_bb0265","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0270","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.151.4.879","article-title":"Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones","volume":"151","author":"Engsig","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.156.1.1","article-title":"Matrix metalloproteinases in immunity","volume":"156","author":"Goetzl","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2010.06.007_bb0280","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0002-9440(10)63483-9","article-title":"Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy","volume":"163","author":"Burke","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2010.06.007_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI7091","article-title":"Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption","volume":"105","author":"Haro","year":"2000","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bone.2010.06.007_bb0290","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1055\/s-0037-1615921","article-title":"Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth","volume":"82","author":"Shapiro","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bone.2010.06.007_bb0295","doi-asserted-by":"crossref","first-page":"25854","DOI":"10.1074\/jbc.M109.033472","article-title":"Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)\/FGFR-2 pathway","volume":"284","author":"Ardi","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0300","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2008.07.001","article-title":"T cells potentiate PTH-induced cortical bone loss through CD40L signaling","volume":"8","author":"Gao","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.bone.2010.06.007_bb0305","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.bor.0000231909.35043.da","article-title":"New insights into the role of T cells in the vicious cycle of bone metastases","volume":"18","author":"Fournier","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.bone.2010.06.007_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.1.3.1","article-title":"Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix","volume":"3","author":"Eckhardt","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0315","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.4049\/jimmunol.171.8.4340","article-title":"Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor","volume":"171","author":"Owen","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2010.06.007_bb0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15216540601187795","article-title":"Defining the roles of T cell membrane proteinase and CD44 in type 1 diabetes","volume":"59","author":"Savinov","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bone.2010.06.007_bb0325","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10555-006-9033-z","article-title":"Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP)","volume":"25","author":"Liao","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bone.2010.06.007_bb0330","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/ijc.23602","article-title":"Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions","volume":"123","author":"Liao","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0335","first-page":"6015","article-title":"Parathyroid hormone-related protein as a growth regulator of prostate carcinoma","volume":"59","author":"Dougherty","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0340","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbrc.2004.11.162","article-title":"Direct evidence that PTHrP expression promotes prostate cancer progression in bone","volume":"327","author":"Deftos","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2010.06.007_bb0345","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/en.140.10.4451","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.06.007_bb0350","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/bjc.1995.397","article-title":"Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours","volume":"72","author":"Southby","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0355","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(01)65919-6","article-title":"Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts","volume":"156","author":"Cramer","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.bone.2010.06.007_bb0360","first-page":"E832","article-title":"Processing of pro-PTHRP by the prohormone convertase, furin: effect on biological activity","volume":"268","author":"Liu","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bone.2010.06.007_bb0365","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-007-9516-9","article-title":"On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer","author":"Smollich","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bone.2010.06.007_bb0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2490-7-3","article-title":"Differential expression of CD10 in prostate cancer and its clinical implication","volume":"7","author":"Dall'Era","year":"2007","journal-title":"BMC Urol"},{"key":"10.1016\/j.bone.2010.06.007_bb0375","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1359\/jbmr.2000.15.7.1266","article-title":"Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides","volume":"15","author":"Ruchon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0380","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.bjp.0703830","article-title":"A N-terminal PTHrP peptide fragment void of a PTH\/PTHrP-receptor binding domain activates cardiac ET(A) receptors","volume":"132","author":"Schluter","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bone.2010.06.007_bb0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0074-7696(04)39002-9","article-title":"Structure, evolutionary conservation, and functions of angiotensin- and endothelin-converting enzymes","volume":"239","author":"Macours","year":"2004","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.bone.2010.06.007_bb0390","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.85.10.906","article-title":"Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor","volume":"85","author":"Fernandez-Patron","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0395","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/CS20050286","article-title":"Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma","volume":"110","author":"Felx","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.bone.2010.06.007_bb0400","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2010.06.007_bb0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","article-title":"Regulation of matrix metalloproteinases: an overview","volume":"253","author":"Chakraborti","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bone.2010.06.007_bb0410","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0415","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI119435","article-title":"Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2","volume":"99","author":"Yoneda","year":"1997","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bone.2010.06.007_bb0420","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1074\/mcp.M000050-MCP201","article-title":"Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics","volume":"9","author":"Prudova","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.bone.2010.06.007_bb0425","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gad.925702","article-title":"CD44 anchors the assembly of matrilysin\/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling","volume":"16","author":"Yu","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2010.06.007_bb0430","doi-asserted-by":"crossref","first-page":"31730","DOI":"10.1074\/jbc.272.50.31730","article-title":"Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site","volume":"272","author":"Suzuki","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0435","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10555-006-9022-2","article-title":"The role of Wnts in bone metastases","volume":"25","author":"Hall","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bone.2010.06.007_bb0440","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1158\/0008-5472.CAN-05-2919","article-title":"Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis","volume":"66","author":"Blavier","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0445","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/MCB.21.4.1370-1383.2001","article-title":"The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors","volume":"21","author":"Crawford","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0450","doi-asserted-by":"crossref","first-page":"17535","DOI":"10.1074\/jbc.M311292200","article-title":"The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway","volume":"279","author":"Zilberberg","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0455","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1074\/jbc.M311569200","article-title":"The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells","volume":"279","author":"Rozanov","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0460","doi-asserted-by":"crossref","unstructured":"T. Ara, Y.A. Declerck. Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 46: 1223-1231.","DOI":"10.1016\/j.ejca.2010.02.026"},{"key":"10.1016\/j.bone.2010.06.007_bb0465","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.144.11.4226","article-title":"IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release","volume":"144","author":"Kurihara","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2010.06.007_bb0470","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.4049\/jimmunol.155.11.5198","article-title":"A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor","volume":"155","author":"Mullberg","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2010.06.007_bb0475","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.06.007_bb0480","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bone.2010.06.007_bb0485","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","article-title":"Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival","volume":"274","author":"Lum","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0490","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1074\/jbc.M010741200","article-title":"Biochemical and pharmacological criteria define two shedding activities for TRANCE\/OPGL that are distinct from the tumor necrosis factor alpha convertase","volume":"276","author":"Schlondorff","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0495","doi-asserted-by":"crossref","first-page":"22331","DOI":"10.1074\/jbc.M302781200","article-title":"Catalytic properties of ADAM19","volume":"278","author":"Chesneau","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0500","doi-asserted-by":"crossref","first-page":"36846","DOI":"10.1074\/jbc.M606656200","article-title":"Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand","volume":"281","author":"Hikita","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0505","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jcp.20147","article-title":"Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen","volume":"202","author":"Dallas","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bone.2010.06.007_bb0510","series-title":"Martin T","author":"Bilezikian","year":"2008"},{"key":"10.1016\/j.bone.2010.06.007_bb0515","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.ju.0000141582.15218.10","article-title":"Molecular insights into prostate cancer progression: the missing link of tumor microenvironment","volume":"173","author":"Chung","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.bone.2010.06.007_bb0520","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1359-6101(99)00010-6","article-title":"Latent transforming growth factor-beta binding proteins (LTBPs)\u2014structural extracellular matrix proteins for targeting TGF-beta action","volume":"10","author":"Saharinen","year":"1999","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bone.2010.06.007_bb0525","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1083\/jcb.131.2.539","article-title":"Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein","volume":"131","author":"Dallas","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0530","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2010.06.007_bb0535","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1359\/jbmr.2001.16.7.1281","article-title":"Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles","volume":"16","author":"Maeda","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0540","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s002230010032","article-title":"The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3)","volume":"70","author":"Maeda","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2010.06.007_bb0545","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3220809","article-title":"Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release","volume":"322","author":"Imai","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.bone.2010.06.007_bb0550","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00666208","article-title":"Osteolytic bone metastasis in breast cancer","volume":"32","author":"Yoneda","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bone.2010.06.007_bb0555","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/01.blo.0000093055.96273.69","article-title":"Transforming growth factor-beta in osteolytic breast cancer bone metastases","author":"Guise","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0560","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1349-7006.2008.01012.x","article-title":"Transforming growth factor-beta signaling at the tumor\u2013bone interface promotes mammary tumor growth and osteoclast activation","volume":"100","author":"Futakuchi","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bone.2010.06.007_bb0565","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1359\/jbmr.061005","article-title":"TGF-beta promotes the establishment of renal cell carcinoma bone metastasis","volume":"22","author":"Kominsky","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0570","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1359\/JBMR.040509","article-title":"(Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts","volume":"19","author":"Perez-Amodio","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0575","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q","article-title":"Regulation of the differentiation and function of osteoclasts","volume":"192","author":"Chambers","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.bone.2010.06.007_bb0580","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.4049\/jimmunol.170.7.3679","article-title":"The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast\/macrophage lineage commitment in vitro","volume":"170","author":"Fox","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2010.06.007_bb0585","first-page":"2631","article-title":"Osteoblast-related transcription factors Runx2 (Cbfa1\/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells","volume":"63","author":"Barnes","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0590","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI113885","article-title":"Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures","volume":"83","author":"Canalis","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2010.06.007_bb0595","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bone.2006.02.068","article-title":"Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling","volume":"39","author":"Jiang","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.007_bb0600","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.critrevonc.2005.10.003","article-title":"Insulin-Like Growth Factor (IGF) family and prostate cancer","volume":"58","author":"Gennigens","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bone.2010.06.007_bb0605","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cytogfr.2005.04.004","article-title":"Molecular interactions of the IGF system","volume":"16","author":"Denley","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bone.2010.06.007_bb0610","doi-asserted-by":"crossref","first-page":"25742","DOI":"10.1016\/S0021-9258(18)47310-3","article-title":"Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures","volume":"269","author":"Fowlkes","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0615","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1210\/en.136.8.3527","article-title":"Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation","volume":"136","author":"Thrailkill","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.06.007_bb0620","doi-asserted-by":"crossref","first-page":"25706","DOI":"10.1074\/jbc.272.41.25706","article-title":"Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3","volume":"272","author":"Manes","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0625","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2010.06.007_bb0630","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1432-0436.2002.700904.x","article-title":"The organ microenvironment and cancer metastasis","volume":"70","author":"Fidler","year":"2002","journal-title":"Differentiation"},{"key":"10.1016\/j.bone.2010.06.007_bb0635","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1158\/0008-5472.CAN-06-0459","article-title":"Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121\/rGel","volume":"66","author":"Mohamedali","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0640","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/0008-5472.CAN-03-1382","article-title":"Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein","volume":"64","author":"Dai","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0645","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0650","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-09-0445","article-title":"Osteoclast-Derived Matrix Metalloproteinase-9 Directly Affects Angiogenesis in the Prostate Tumor\u2013Bone Microenvironment","author":"Bruni-Cardoso","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0655","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10585-006-9042-x","article-title":"Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis","volume":"23","author":"Nabha","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bone.2010.06.007_bb0660","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood-2009-08-237628","article-title":"Osteoclasts are important for bone angiogenesis","volume":"115","author":"Cackowski","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bone.2010.06.007_bb0665","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.200409115","article-title":"Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors","volume":"169","author":"Lee","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2010.06.007_bb0670","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1074\/jbc.M201674200","article-title":"Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165","volume":"277","author":"Hashimoto","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0675","doi-asserted-by":"crossref","first-page":"43503","DOI":"10.1074\/jbc.M107736200","article-title":"Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1","volume":"276","author":"McQuibban","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.007_bb0680","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bone.2010.06.007_bb0685","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0959-8049(00)00363-4","article-title":"A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu\/nu mice","volume":"37","author":"Lee","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bone.2010.06.007_bb0690","first-page":"1932","article-title":"Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice","volume":"8","author":"Winding","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bone.2010.06.007_bb0695","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/ijc.21645","article-title":"Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor 1","volume":"118","author":"Bonfil","year":"2006","journal-title":"Int J Cancer"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210013001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210013001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T16:50:20Z","timestamp":1685638220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328210013001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S8756328210013001"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2010.06.007","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}